当前位置: 首页 > 期刊 > 《青春期健康》 > 2019年第1期
编号:13331003
2018全球哮喘防治倡议哮喘指南解读(3)
http://www.100md.com 2019年1月1日 《青春期健康·下半月》 2019年第1期
     [11]李靖,孔維佳,林江涛,等.中国特异性免疫治疗的临床实践专家共识[J].中华结核和呼吸杂志,2012,35(3):163-166.

    [12] Lange P,Celli B,Agusti A,et al.Lung-function trajectories leading to chronic obstrctive pulmonary disease[J].N Engl J Med,2015,373(2):111-122.

    [13] Global Initiative for Chronic Obstructive Lung Disease(GOLD):Global Strategy for the Diagnosis Management and prevention of Chronic Obstructive Lung Disease.2018.http://www.glodcopd.org.

    [14] Gershon AS,Campitelli MA,Croxford R,et al.Combination longacting β-agonists and inhaled corticosteroids compared with longacting β-agonists alone in older adults with chronic obstructive pulmonary disease[J].JAMA,2014,312(11):1114-1121.

    [15]林江涛.支气管哮喘急性发作评估及处理中国专家共识[J].中华内科杂志,2018,57(1):4-14.

    [16] Best KP,Gold M,Kennedy D,et al.Omega-3 long-chain PUFA intake during pregnancy and allergic disease outcomes in the offspring: a systematic review and meta-analysis of observational studies and randomized controlled trials[J].Am J Clin Nutr,2016,103(1):128-143.

    [17] Fitzpatrick AM,Jackson DJ,Mauger DT,et al. Individualized therapy for persistent asthma in young children[J].J Allergy Clin Immunol,2016,138(6):1608-1618.e12., http://www.100md.com(张清玲)
上一页1 2 3